Article
Assessment of genome mutation analysis for tumor-informed detection of circulating tumor DNA in patients with breast cancer.
Clinica chimica acta; international journal of clinical chemistry - 15 Jul 2024
Wahab Mugip Rahaman Abdul, Palaniyandi Thirunavukkarasu, Thamada Swarnakala, Viswanathan Sandhiya, Baskar Gomathy, Surendran Hemapreethi, Baraneedharan P, Kannan J, Ravi Maddaly, Rajinikanth Suba, El-Tayeb Mohamed A, Syed Shaban
Abstract excerpt
INTRODUCTION: Breast cancer, one of the most aggressive types of cancer, poses significant challenges for diagnosis and treatment. Emerging as a promising biomarker, circulating tumor DNA (ctDNA) can be used to identify and monitor disease risk. This study sought to examine the impact of mutations in various genes on the progression of breast cancer. Genetic variants associated with breast cancer have been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
